Kenneth S. Yamamoto

Oncology | Hematology Oncology

1800 Sullivan Ave
Suite 603
Daly City, CA 94015

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma.

Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma.

Journal: Anticancer research

Published: September 12, 2013

Showing 1-1 of 1

Last Updated: 09/26/2026